Objective: The long-term effects and mechanisms of early started angiotensin converting enzyme (ACE) inhibition post myocardial infarction (MI) are not well understood. Chronic effects of early ACE inhibition on hemodynamics, left ventricular diastolic wall stress and remodeling were, therefore, compared to that of angiotensin AT -receptor subtype blockade in rats with experimental myocardial 1 infarction. The contribution of bradykinin potentiation to both ACE inhibitor and angiotensin AT -receptor subtype blockade was 1 assessed by cotreatment of rats with a bradykinin B2-receptor antagonist. Methods: MI was produced by coronary artery ligation in adult male Wistar rats. The ACE inhibitor, quinapril (6 mg / kg per day), or the angiotensin AT -receptor subtype blocker, losartan (10 mg / kg 1 per day), administered by gavage, and the bradykinin B2-receptor antagonist, Hoe-140 (500 mg / kg per day s.c.), administered either alone or in combination with quinapril or losartan, were started 30 min after MI and continued for eight weeks. Results: Quinapril and losartan reduced left ventricular end-diastolic pressure and global left ventricular diastolic wall stress only in rats with large MI. Pressure volume curves showed a rightward shift in proportion to MI size that was not prevented by quinapril or losartan treatment. Only the ACE inhibitor reduced left ventricular weight and this effect was prevented by cotreatment with the bradykinin antagonist. Baseline and peak cardiac index and stroke volume index, as determined using an electromagnetic flowmeter before and after an acute intravenous volume load, were restored by quinapril, whereas losartan had no effects. Conclusion: Treatments starting 30 min after coronary artery ligation, with either quinapril or losartan, reduced preload only in rats with large MI. Despite this unloading of the heart, structural dilatation was not prevented by this early treatment. Only quinapril improved cardiac performance and reduced left ventricular weight and this effect was abolished by cotreatment with Hoe-140, suggesting an angiotensin II blockade-independent, but bradykinin potentiation-dependent, mechanism.
Introduction
progressive ventricular dilatation exists from the time of coronary occlusion and infarction [4, 5, [8] [9] [10] [11] [12] [13] . It might be Angiotensin converting enzyme (ACE) inhibitors are important, therefore, to start ACE inhibitor therapy as soon beneficial in the prevention of left ventricular dilatation, as possible after myocardial infarction (MI) [1, [14] [15] [16] . heart failure and death post myocardial infarction [1] [2] [3] .
However, it could also block early compensatory mechaLeft ventricular dilatation appears to play a key role in the nisms, including early compensatory left ventricular dilatadevelopment of heart failure [1, 2, [4] [5] [6] and for prognosis tion [5] . Treatment with captopril 2 h, two days or three [7] in patients after a large infarct. The potential for weeks after acute MI has beneficial effects in the rat MI model [1, 2, 17] . In contrast, in the clinical CONSENSUS II study [18] , treatment with enalapril was started within 24 h 7025 rodent ventilator, Hugo Sachs Elektronik, March, of acute MI, but patients showed no improvement in Germany), and a left thoracotomy was performed. The survival over the 180 days after infarction. In contrast, the heart was exteriorized from the thorax, and the left acute application of ACE inhibitors along with thromcoronary artery was ligated using a 5.0 suture between the bolytic therapy showed some survival benefits as early as pulmonary artery outflow tract and the left atrium. The five-six weeks after the infarct [19, 20] . Thus, the longheart was then returned to its normal position and the term effects of early started treatment with ACE inhibitors thorax was closed. All procedures conformed to the post infarct are not well understood.
''Position of the American Association on Research AniIn addition, it remains unclear so far whether or not the mal Use'' and were approved by the institutional animal effect of ACE inhibitors is mediated by prevention of research committee. angiotensin II (AII) generation. AII receptor-independent Twenty-four groups of rats were studied: The six effects have also been suggested [21] [22] [23] . Specific AII treatment groups included untreated control rats, a group receptor antagonists have only recently become available treated with quinapril (6 mg / kg / day), a group treated with [24] . Raya et al. [24] reported that treatment for two weeks losartan (10 mg / kg), a group treated with Hoe-140 (500 with captopril or the AII receptor antagonist losartan, mg / kg / day), a group treated with quinapril plus Hoe-140, initiated three weeks after large infarction in rats, deand a group treated with losartan and Hoe-140. According creased left ventricular end-diastolic pressure and left to the extent of the histologic infarct size, an additional ventricular end-diastolic volume index and increased venfour subgroups were established in each treatment group. ous compliance. These data suggested that specific blocThese included rats in which failure of ligation of the kade of AII was sufficient to explain the benefits of ACE coronary artery occurred (sham), in which infarcts were inhibitors. Smits et al. [25] , who started treatment during less than 30% (small), ranged from 30 to ,45% (moder-(1-21 days) and after (21-35 days) completion of the ate) or were 45% and larger (large). Treatments were repair phase of MI, suggested that the effects of captopril started by gavage 30 min after coronary artery ligation or in rats after MI were not dependent on AII. Most recently, sham operation and were repeated daily for eight weeks. Schieffer et al. [26] suggested similar effects of ACE Animals were housed in polyethylene cages in climatized inhibition and angiotensin AT -receptor subtype blockade rooms with a 12-h light-dark cycle and fed with standard 1 in preventing important features of ventricular remodeling laboratory food and tap water. after MI. Moreover, it is suggested that multiple actions relevant to cardiovascular control of ACE inhibitors were 2.2. Angiotensin I dose-response curves related in part to bradykinin potentiation, and cotreatment with a bradykinin receptor antagonist abolished all ACE
In pilot experiments, the pressor response to angiotensin inhibitor-induced effects on cardiac function in stroke-I (AI) of the applied quinapril and losartan dosage was prone spontaneously hypertensive rats [27] . Finally, the tested. Rats were pretreated with quinapril (6 mg / kg body important role of myocardial infarct size has not been weight, n55), losartan (10 mg / kg body weight, n55) or analyzed for the effect of early treatment with ACE water (n55) and AI (1-25 mg / kg / min) was infused 6 h inhibitors or AII receptor antagonists. It remains unclear so after the respective treatment. The dose-response curves far why ACE inhibitors reduced left ventricular volume demonstrated that the inhibition of AI pressor response by only in animals with large infarcts [1] . Therefore, we either drug was equipotent (Fig. 1) . studied the chronic effects on hemodynamics, left ventricular volume and wall stress of ACE inhibition by quinapril 2.3. Hemodynamic measurements and left ventricular or blockade of AII receptor by losartan. The contribution volume of bradykinin potentiation to both ACE inhibitor-and AII blocker actions was also assessed by cotreatment of rats Eight weeks after coronary artery ligation, rats were with the bradykinin B2-receptor antagonist, Hoe-140. All reanesthetized with ether. Polyethylene cannulas were drugs were initiated 30 min after coronary artery ligation.
inserted into the trachea for artificial ventilation, into the right carotid artery and jugular vein, and into a femoral vein. Pressures were measured through a short segment of 2. Methods fluid-filled PE 50 tubing, connected to a microtip manome-® ter (Millar ) via a three-way stopcock, with zero adjusted 2.1. Animals, experimental myocardial infarction and to mid-chest level. The carotid cannula was briefly adpharmacologic interventions vanced into the left ventricle, then withdrawn to the aortic arch while pressures were recorded. The jugular vein Adult male Wistar rats, weighing 280-300 g when the cannula was advanced to the right atrium. Left ventricular study was started, were used and coronary artery ligation systolic pressure (LVSP) and end-diastolic pressure was performed as described previously by Pfeffer et al. [1] .
(LVEDP), the maximum rate of rise of left ventricular In brief, rats were anesthetized by ether, intubated and systolic pressure, dP/ dt , the mean arterial pressure max ventilated by a volume-constant rodent ventilator (UB (MAP), heart rate (HR) and the mean right atrial pressure were obtained as previously described [6] . The heart was arrested using potassium chloride and a double-lumen catheter (PE 50 inside PE 200) was inserted into the left ventricle via the ascending aorta. The right ventricular free wall was incised to avoid fluid accumulation. The atrioventricular groove was ligated and isotonic saline was infused at a rate of 0.76 ml / min via one lumen, while intraventricular pressure was continuously recorded through the other lumen, from negative pressure to 30 mmHg. Three reproducible pressure-volume curves were obtained within 10 min of cardiac arrest, well before the onset of rigor mortis. The operating left ventricular end-diastolic volume was derived from the left ventricular pressure-volume curve [1, 15] . It was defined as the volume on the pressurevolume curve corresponding to a filling pressure equal to in vivo end-diastolic pressure. Analysis of global ventricu- The method used to process the heart for the measurewas obtained electronically and taken as the cardiac index ment of infarct size was similar to that previously de-(CI), as described by Pfeffer et al. [1] . The systemic scribed [1, 30] . After the pressure-volume data had been vascular resistance index (SVRI) was calculated as recorded, the hearts were fixed in distended form in 10% (MAP2RAP) / CI and was expressed as mmHg / ml / min / buffered formalin for 24 h, then dissected into left ventricle kg body weight.
plus interventricular septum and right ventricular free wall, After baseline measurements, warmed (39-408C) which were weighed separately. The whole left ventricle Tyrode's solution was infused into a femoral vein at a rate was dehydrated in alcohol, cleared in xylene, and embedof 40 ml / kg / min for 45 s or until maximal flow was ded in paraffin. Transverse serial sections of 20 mm achieved [1] . This infusion produced a rise in cardiac thickness were obtained in 1 mm intervals from apex to output to peak values, followed by a plateau, despite base, mounted and stained with phosphotungstic acidfurther elevation of right atrial pressure. Maximum cardiac hematoxylin so that necrotic infarct tissue stained red and performance was defined as peak values of cardiac output non-infarcted myocardium blue. The slices were projected (CI ) and stroke volume (SVI ) during this infusion of and the lengths of infarct and total left ventricle on both max max
Tyrode's solution. epicardial and endocardial surfaces of each section were Ten to 15 min after the volume load, when all hemomeasured using a calibrated digitizer (Numonics Digitizer ® dynamic variables had returned to baseline levels, the 2200 ). Infarct size was calculated by dividing the sum of flowmeter was removed and the arterial catheter was the planimetered endocardial and epicardial circumferences advanced into the left ventricle. The ascending aorta was occupied by the infarct by the sum of the total epicardial briefly occluded around the catheter by a suture, to produce and endocardial circumferences of the left ventricle. contractions that were isovolumic except for coronary flow. Measurements were made of left ventricular peak systolic and end-diastolic pressure. Maximal left ventricu-3. Data analysis lar developed pressure was calculated as the peak systolic minus end-diastolic pressure during aortic occlusion. These
Results are expressed as mean6SEM. Statistical commeasurements defined the maximal pressure-generating parisons among infarct and treatment groups were evaluability of the left ventricle, as previously described [28] .
ated by ANOVA and significant difference was determined Then, a second volume loading was applied to determine by the Bonferroni test. P,0.05 was considered to indicate the peak left ventricular end-diastolic pressures.
statistical significance. For the difference in mortality, The passive pressure-volume curves of the left ventricle Kaplan-Meier-Survival analysis was performed and dif- Table 2 ferences between the groups were tested for significance Heart weights by the log-rank statistic using the Cox-Mantel test. sham rats and rats with small MI and these effects were abolished by cotreatment with Hoe-140. Right ventricular weight to body weight ratio was increased in untreated rats with large MI. Hoe-140 increased right ventricular weight, As shown in the CI and SVI in proportion to infarct size. Quinapril 4.4. Peak cardiac performance prevented this reduction of CI and SVI post-infarction, while losartan did not. The total peripheral resistance index Peak CI and SVI (Table 5) were reduced in untreated (TPRI) was increased in untreated rats with moderate and rats in proportion to infarct size. These parameters were large MI, and both quinapril and losartan significantly not affected by losartan, however, quinapril prevented this reduced TPRI, however, the effect was more pronounced reduction of CI and SVI. Peak LVEDP during volume after quinapril and consistent throughout all groups with loading was increased by large MI in untreated rats. Both infarction. After cotreatment with Hoe-140, the effect of quinapril and losartan tended to prevent the increase in quinapril on CI was abolished but the effect of quinapril on peak LVEDP by large MI. Peak developed pressure was TPRI was not affected.
decreased in proportion to infarct size in untreated rats. Quinapril or losartan treatment reduced peak developed ment with Hoe-140 (not shown). Operating left ventricular pressure in sham rats and in rats with small MI, but not in volume and its ratio to left ventricular weight are shown in rats with moderate or large MI. The ratio of peak de- Fig. 2A-B . Volume was significantly increased in untreated veloped left ventricular pressure to left ventricular weight rats with moderate or large MI, significantly reduced by also decreased in untreated rats with moderate and large quinapril and tended to be reduced by losartan treatment in MI. The reduction of developed pressure by quinapril and rats with large infarction. These effects were partially losartan in sham-operated animals disappeared after corabolished after cotreatment with Hoe-140 in the quinapril rection for left ventricular weight. The effects on peak CI group and were completely abolished in the losartan group. after quinapril, and decreased peak LVEDP by quinapril and losartan, in rats with large MI were abolished after 4.6. Left ventricular diastolic wall stress cotreatment with Hoe-140.
Diastolic wall stress (Fig. 3) significantly increased only 4.5. Left ventricular volume in animals with large infarcts and, in these animals, only quinapril and losartan significantly reduced wall stress. Pressure volume curves showed a rightward shift in Quinapril reduced diastolic wall stress to about 30% in proportion to MI size in untreated rats, which was not animals with large infarcts, despite treatment with Hoeaffected by quinapril or losartan treatment or by cotreat-140. 
5
. Discussion mortality, as tested for the total groups. The study answers in part the question of why ACE inhibitors prevent left The study failed to show a prevention of structural ventricular dilatation only in certain subgroups of indilatation of the left ventricle when therapy with an ACE dividuals with myocardial infarction. Pfeffer et al. [1] inhibitor or AII receptor antagonist was started 30 min reported a reduction in left ventricular operating volume after coronary occlusion. The study is limited to permanent only in rats with large infarcts. In the present study, both coronary occlusion and may not apply to the clinical the ACE inhibitor and the AII receptor antagonist reduced situation when reperfusion may be achieved. Neither diastolic wall stress only in animals with large infarcts. In quinapril nor losartan had an effect on infarct size or addition, the study shows basic differences between the ACE inhibitor and the angiotensin AT -receptor subtype and increased septal thickness [31] . One limitation of this 1 antagonist. First, the ACE inhibitor reduced systemic and other studies is that we used weight to estimate vascular resistance independently of infarct size, while the ''hypertrophy'' [1, 17, [24] [25] [26] . As shown previously, strucangiotensin AT -receptor subtype blocker reduced resisttural left ventricular dilatation occurred in proportion to 1 ance only in animals with moderate or large infarcts. infarct size [1, 6, 31, 32] . Second, only the ACE inhibitor significantly reduced left Our data, together with those in the literature, suggest ventricular weight. Third, only the ACE inhibitor increased that ACE inhibitors, in a manner that is independent of the the cardiac index in rats with large infarcts. A striking specific type of drug and the timing of treatment, prevent effect of the bradykinin antagonist Hoe-140 was that it hypertrophy of surviving myocardium or produce some increased LVEDP in all animal groups, including shamtype of ''atrophy'' in sham-operated animals [1, 17, 26] . operated animals. Perhaps as a consequence of an inThe pathophysiologic consequence of the latter remains creased right ventricular afterload, Hoe-140 substantially dubious. In contrast, the angiotensin AT -receptor subtype 1 increased right ventricular weight. In contrast, Hoe-140 did blocker, losartan, had no effect on left ventricular weight. not change systemic vascular resistance or right atrial
The conflicting reports on the effect of ACE inhibitors and pressure and did not prevent the vasodilator effects of angiotensin AT -receptor subtype blockers on heart weight 1 quinapril or losartan. Left ventricular weight reduction and post MI may be due to various doses and timings of an increase in the cardiac index by the ACE inhibitor was treatments or the effects of ACE inhibitors that are abolished by the bradykinin antagonist.
independent of AII [24] [25] [26] [33] [34] [35] . Our data suggest that, in this model, in contrast to the situation in the sponta-5.1. Weights, volume and wall stress neously hypertensive rat (SHR) [36] or due to volume overload induced by aortocaval shunt [37] , AII does not Myocardial infarction induced hypertrophy of surviving act as a growth promoting factor [38] by stimulation of the myocardium, as suggested by unchanged left ventricular AT receptor blocked by losartan. Systolic load (LVSP, 1 weight in the presence of reduced free wall (scar) thickness MAP, TPRI) was somewhat lower with quinapril than with losartan only in animals with MI, and diastolic wall stress load but not preload (hydralazine) do not prevent left was identical (see below). Thus, differences in mechanical ventricular dilatation [15] . Accordingly, quinapril and factors may not conclusively explain differences between losartan reduced the left ventricular operating volume only the drug effects on LV weight. The ACE inhibitor may in those animals in which they reduced diastolic wall interfere with hypertrophy [1, 15, 16, 39, 40] by bradykinin stress, i.e., those with large infarcts. Quinapril reduced potentiation [21] [22] [23] , prostaglandins and EDRF (NO) diastolic wall stress to about 30% in animals with large release [41, 42] . In fact, decreased LV-to-body weight infarcts, despite treatment with Hoe-140, suggesting that ratios, elicited by quinapril in sham rats and rats with small this effect is not associated with bradykinin. Consequently, MI, were restored after cotreatment with Hoe-140, supportthe effect of quinapril on operating volume was also not ing a role of bradykinin potentiation by the ACE inhibitor abolished by cotreatment with Hoe-140, in accordance for prevention of hypertrophy in this model. McDonald et with the close interdependence among LVEDP, diastolic al. also showed that the antigrowth effect of the ACE wall stress and operating volume. inhibitor ramipril was prevented in the direct current shock model in dog by cotreatment with Hoe-140 [43] . The 5.2. Hemodymamics and cardiac performance striking gain of right ventricular weight caused by Hoe-140 may also reflect, in part, prevention of the ''antitrophic'' A significant reduction in peripheral resistance by effects of bradykinin.
losartan occurred only in animals with moderate-to-large Neither quinapril nor losartan treatment showed a infarcts. Cardiac filling pressures (right atrial and left significant effect on the rightward shift of the in situ ventricular end-diastolic pressure) were also reduced by obtained pressure volume curve of arrested left ventricles quinapril and losartan only in animals with large infarcts. or of ventricular diameters determined in vitro. End-diasActivation of the renin-angiotensin system does not occur tolic volume at in vivo left ventricular end-diastolic consistently in this model [44, 45] and is probably a pressure (''operating volume'') was, however, reduced by prerequisite for the systemic vasodilator effect of losartan quinapril and tended to be lowered by losartan in rats with [46] . In animals with moderate-to-large infarcts, this large myocardial infarcts ( Fig. 2A) . This effect was prerequisite might be fulfilled [45] . Since cotreatment with primarily the result of a decrease in left ventricular endHoe-140 did not reverse the lowering effect of quinapril or diastolic pressure. Previous studies using ACE inhibitors in losartan on arterial pressure and systemic vascular resistdifferent protocols post myocardial infarction have also ance, these data strongly argue against a bradykinin-depenreported major effects on the operating left ventricular dent mechanism. volume rather than on the pressure-volume curve [1, 24] .
Depressed cardiac index and stroke volume index in rats Importantly, however, the operating left ventricular volwith MI were restored by quinapril at baseline and peak ume-to-weight ratio (Fig. 2B ) was also decreased in rats during volume load, but not consistently by losartan. This with large MI by quinapril and, again, tended to be finding is consistent with previous work by Smits et al. lowered by losartan, suggesting decreased wall stress.
[25], who reported a fall in blood pressure and a reduction Chronic bradykinin B2 receptor blockade with Hoe-140, as in total peripheral resistance, but no improvement in mentioned above, substantially increased LVEDP and cardiac output, in rats treated for 1-21 days post MI with resulted in higher LVEDP also in animals treated with losartan. Our data are also consistent with studies by quinapril and losartan. However, both quinapril and losarPfeffer et al. [1] and Gay [17] , in that similar effects were tan tended to reduce LVEDP even in animals treated with found on treatment with captopril, administered 2 h, two Hoe-140, suggesting that this effect was not exclusively days or 21 days after coronary occlusion. In contrast, mediated by bradykinin.
Schoemaker et al. [47] found that captopril treatment that An estimate of global diastolic wall stress, as previously was started one day after coronary occlusion failed to described by Teerlink et al. [29] , increased 30-fold in improve ventricular function. The fact that these effects of animals with large infarcts vs. sham-operated animals, and quinapril could be partially abolished by cotreatment with was reduced to one fourth by quinapril and losartan, Hoe-140 suggest a role of bradykinin potentiation, howrespectively. Hemodynamic data suggest that these aniever, the exact mechanism remains unclear. An explanamals, eight weeks after a large infarct, resemble a model of tion may be that quinapril, in the presence of Hoe-140, heart failure with reduced left ventricular dp / dt , inlowered LVEDP and diastolic wall stress, but not nearly as max creased left ventricular end-diastolic pressure and right much as in the absence of Hoe-140. This could well be a atrial pressure, reduced stroke volume index and increased bradykinin-independent effect. total peripheral resistance index. In contrast, these changes were variable and inconsistent in the animals with moderate infarcts and, frankly, were absent in those with small 6. Quinapril versus losartan infarcts. Thus, both quinapril and losartan substantially reduce diastolic wall stress in the rat model of heart failure, 6.1. Similarities but not in that of compensated left ventricular dysfunction. Previous studies have shown that drugs that reduce afterBoth losartan and quinapril had vasodilator properties 
